Advances in Anti-Inflammatory Therapeutics: 20-21 November 2006, London, UK.
This meeting highlighted early discovery to early clinical development of anti-inflammatory drugs. New compounds included kinase inhibitors, receptor modulators and an extended use for an existing drug, lenalidomide, in a further indication. Risk mitigation strategies to improve the likelihood of clinical success was a dominant feature of the meeting.
Braddock
Martin
M
Discovery Bioscience, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire, LE11 5RH, UK. martin.braddock@astrazeneca.com
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000517:prevention & control; D008131:London
D000893:Anti-Inflammatory Agents; D015507:Drugs, Investigational